10,474 Results

FDA gives premarket approval to Therascreen PIK3CA Kit as companion diagnostic for breast cancer.- Qiagen

 Added 13 hours ago

Qiagen announced the immediate launch of its Therascreen PIK3CA RGQ PCR Kit (therascreen PIK3CA Kit) after it received U.S. regulatory...

TSolution One surgical system filed for 510(k) approval with FDA for knee replacement.- THINK Surgical

 Added 13 hours ago

THINK Surgical has completed enrollment for the U.S. investigational clinical study and submission of the 510(k) to obtain clearance from...

FDA approves Jakafi for the treatment of steroid-refractory acute graft versus host disease. Incyte + Novartis

 Added 13 hours ago

Incyte Corporation has announced that the FDA has approved Jakafi (ruxolitinib) for the treatment of steroid-refractory acute GVHD in adult...

FDA approves Zolgensma to treat spinal muscular atrophy .- Novartis

 Added 13 hours ago

AveXis, a Novartis company, announced that the FDA has approved Zolgensma (onasemnogene abeparvovac-xioi), one-time dose of gene therapy , for...

FDA approves Piqray + fulvestrant to treat hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-), PIK3CA-mutated, advanced or metastatic breast cancer.- Novartis

 Added 1 day ago

Novartis announced the FDA has approved Piqray (alpelisib, formerly BYL 719) in combination with fulvestrant for the treatment of postmenopausal...

Merck Inc., acquires Peloton Therapeutics and with it PT 2977 , a novel oral HIF-2 alpha inhibitor to treat renal cell carcinoma

 Added 2 days ago

Merck Inc., known as MSD outside the United States and Canada, and Peloton Therapeutics, Inc. announced that the companies have...

OPTION trial initiated to compare WATCHMAN FLX left atrial appendage closure platform to first-line oral anticoagulants

 Added 2 days ago

Boston Scientific Corporation has initiated the OPTION trial to compare safety and effectiveness of the next-generation WATCHMAN FLX left atrial...

Stryker secures FDA PMA for Neuroform Atlas brain aneurysm stent system.

 Added 2 days ago

Stryker announced that it has secured FDA premarket approval for its Neuroform Atlas stent system intended for use in treating...

Pooled phase III data with Xeljanz shows changes that could correlate with CV risk in psoriatic arthritis .- Pfizer

 Added 2 days ago

To investigate the CV risk factors and major adverse cardiovascular events (MACE) in patients with active Psoriatic Arthritis (PsA) receiving...

Nektar Therapeutics announces formation of Inheris Biopharma Inc., a CNS focused company

 Added 2 days ago

Nektar Therapeutics announced the formation of Inheris Biopharma, Inc., a wholly-owned subsidiary of Nektar and a CNS-focused company. Inheris will...

Load more